Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

Chemical Biology Lectureship To Stuart Schreiber

December 20, 2010 | A version of this story appeared in Volume 88, Issue 51

Stuart L. Schreiber, Morris Loeb Professor in the department of chemistry and chemical biology at Harvard University and founding member of the Broad Institute of Massachusetts Institute of Technology and Harvard University, has been awarded the ACS Chemical Biology Lectureship in recognition of his pioneering contributions to research at the interface of chemistry and biology.

Schreiber and his colleagues pioneered the concept of diversity-oriented synthesis and chemical genetics to discover new drug targets and to elucidate new biological pathways, including the fundamental biological importance of histone deacetylation. His current work deals with exploiting new insights into cancer cell genomes to develop novel therapeutic agents by correlating drug efficacies with the genetic features of human cancers.

The lectureship is sponsored jointly by ACS Chemical Biology and the ACS Division of Biological Chemistry. Schreiber will present his lecture at the spring ACS national meeting in Anaheim, Calif.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.